Baseline global white matter hyperintensity volume
Biomarker1 paper1 finding
- Human trial1
Associations
1Neuropsychiatric symptom reduction
downin humans1
1 study
Neuropsychiatric symptom reduction
downin humans1
Baseline global white matter hyperintensity volume is associated with neuropsychiatric symptom reduction in humans (Interaction β = 0.258, SE = 0.080).
Human trialvascular mild cognitive impairment; N-acetylcysteine plus exercise group; WMH × time × treatment interactionbrain white matterN-acetylcysteine 2400 mg daily6 months
Brain scan findings linked to symptom relief in memory trial · Journal of Alzheimer's disease : JAD · 7 Oct 2026
Latest
1Brain scan findings linked to symptom relief in memory trial
In a six-month trial of 51 people with vascular mild cognitive impairment, lower volumes of bright brain areas were linked to greater symptom…In a six-month trial of 51 people with vascular mild cognitive impairment, lower volumes of bright brain areas were linked to greater symptom reductions.